Kastalia Medrano

    Kastalia is Filter‘s deputy editor. She previously worked at half a dozen mainstream digital media outlets and would not recommend the drug coverage at any of them. For a while she was a syringe program peer worker in NYC, where she did outreach hep C testing and navigated participants through treatment. She also writes with Jon Kirkpatrick.

    VT Gov. Vetoes Safe Consumption Site Bill. It May Become Law Without Him.

    Vermont Governor Phil Scott (R) has vetoed legislation that would authorize a safe consumption ...

    Amid DEA War on Meth, Cocaine Is at Last a “Traditional Plant-Based Drug”

    The 2020 National Drug Threat Assessment (NDTA) is such a widely cited document partly ...

    Walgreens Rolls Out $34.99 Naloxone, as Generics and OTC Gain Ground

    Walgreens is rolling out an over-the-counter (OTC) naloxone nasal spray, which it will sell ...

    The Opioid Settlements Being Paid in Naloxone Don’t Quite Add Up

    Amneal Pharmaceuticals, a New Jersey-based manufacturer known for generics, has agreed to settle the ...

    The Delaware Mass Overdose Drugs Aren’t “Naloxone-Resistant”

    On April 30, Delaware State Police (DSP) and the Delaware Department of Health and ...

    FDA Approves Even Higher-Dose Naloxone Nasal Spray, Again

    The Food and Drug Administration has approved a new naloxone nasal spray that contains ...

    If Abstinence Isn’t the Point of Contingency Management, What Is?

    There aren’t any treatments for stimulant use disorder (SUD) that have strong evidence, but ...

    The Campaign to Call Fentanyl Deaths “Poisoning” Is Working as Intended

    A basic concept of toxicology is that “the dose makes the poison.” Any substance ...

    CBP Launches Operation Plaza Spike, “Next Phase” in War on Fentanyl

    Customs and Border Protection (CBP) has begun the latest iteration of its synthetic drug ...